HCW Biologics Stock Forecast - Simple Regression

HCWB Stock  USD 0.97  0.16  14.16%   
The Simple Regression forecasted value of HCW Biologics on the next trading day is expected to be 0.90 with a mean absolute deviation of 0.21 and the sum of the absolute errors of 12.57. HCW Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast HCW Biologics stock prices and determine the direction of HCW Biologics's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of HCW Biologics' historical fundamentals, such as revenue growth or operating cash flow patterns.
At the present time the rsi of HCW Biologics' share price is below 20 . This usually indicates that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards.

Momentum 0

 Sell Peaked

 
Oversold
 
Overbought
The successful prediction of HCW Biologics' future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with HCW Biologics, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting HCW Biologics' stock price prediction:
EPS Estimate Current Year
(2.52)
EPS Estimate Next Year
(4.13)
Wall Street Target Price
35
Quarterly Revenue Growth
(0.99)
Using HCW Biologics hype-based prediction, you can estimate the value of HCW Biologics from the perspective of HCW Biologics response to recently generated media hype and the effects of current headlines on its competitors.
The Simple Regression forecasted value of HCW Biologics on the next trading day is expected to be 0.90 with a mean absolute deviation of 0.21 and the sum of the absolute errors of 12.57.

HCW Biologics after-hype prediction price

    
  USD 0.97  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of HCW Biologics to cross-verify your projections.
For information on how to trade HCW Stock refer to our How to Trade HCW Stock guide.At present, HCW Biologics' Inventory Turnover is projected to increase slightly based on the last few years of reporting. The current year's Receivables Turnover is expected to grow to 6.60, whereas Payables Turnover is forecasted to decline to 0.08. . As of January 2, 2026, Common Stock Shares Outstanding is expected to decline to about 40.3 M. In addition to that, Net Loss is expected to decline to about (14.1 M).

HCW Biologics Additional Predictive Modules

Most predictive techniques to examine HCW price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for HCW using various technical indicators. When you analyze HCW charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
Simple Regression model is a single variable regression model that attempts to put a straight line through HCW Biologics price points. This line is defined by its gradient or slope, and the point at which it intercepts the x-axis. Mathematically, assuming the independent variable is X and the dependent variable is Y, then this line can be represented as: Y = intercept + slope * X.

HCW Biologics Simple Regression Price Forecast For the 3rd of January

Given 90 days horizon, the Simple Regression forecasted value of HCW Biologics on the next trading day is expected to be 0.90 with a mean absolute deviation of 0.21, mean absolute percentage error of 0.07, and the sum of the absolute errors of 12.57.
Please note that although there have been many attempts to predict HCW Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that HCW Biologics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

HCW Biologics Stock Forecast Pattern

Backtest HCW BiologicsHCW Biologics Price PredictionBuy or Sell Advice 

HCW Biologics Forecasted Value

In the context of forecasting HCW Biologics' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. HCW Biologics' downside and upside margins for the forecasting period are 0.01 and 8.03, respectively. We have considered HCW Biologics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
0.97
0.90
Expected Value
8.03
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Simple Regression forecasting method's relative quality and the estimations of the prediction error of HCW Biologics stock data series using in forecasting. Note that when a statistical model is used to represent HCW Biologics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria115.4122
BiasArithmetic mean of the errors None
MADMean absolute deviation0.2061
MAPEMean absolute percentage error0.086
SAESum of the absolute errors12.575
In general, regression methods applied to historical equity returns or prices series is an area of active research. In recent decades, new methods have been developed for robust regression of price series such as HCW Biologics historical returns. These new methods are regression involving correlated responses such as growth curves and different regression methods accommodating various types of missing data.

Predictive Modules for HCW Biologics

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as HCW Biologics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of HCW Biologics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.050.978.04
Details
Intrinsic
Valuation
LowRealHigh
0.050.938.00
Details
1 Analysts
Consensus
LowTargetHigh
31.8535.0038.85
Details

Other Forecasting Options for HCW Biologics

For every potential investor in HCW, whether a beginner or expert, HCW Biologics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. HCW Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in HCW. Basic forecasting techniques help filter out the noise by identifying HCW Biologics' price trends.

HCW Biologics Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with HCW Biologics stock to make a market-neutral strategy. Peer analysis of HCW Biologics could also be used in its relative valuation, which is a method of valuing HCW Biologics by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

HCW Biologics Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of HCW Biologics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of HCW Biologics' current price.

HCW Biologics Market Strength Events

Market strength indicators help investors to evaluate how HCW Biologics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading HCW Biologics shares will generate the highest return on investment. By undertsting and applying HCW Biologics stock market strength indicators, traders can identify HCW Biologics entry and exit signals to maximize returns.

HCW Biologics Risk Indicators

The analysis of HCW Biologics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in HCW Biologics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting hcw stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether HCW Biologics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of HCW Biologics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Hcw Biologics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Hcw Biologics Stock:
Check out Historical Fundamental Analysis of HCW Biologics to cross-verify your projections.
For information on how to trade HCW Stock refer to our How to Trade HCW Stock guide.
You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of HCW Biologics. If investors know HCW will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about HCW Biologics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(16.41)
Revenue Per Share
0.68
Quarterly Revenue Growth
(0.99)
Return On Assets
(0.30)
Return On Equity
(277.26)
The market value of HCW Biologics is measured differently than its book value, which is the value of HCW that is recorded on the company's balance sheet. Investors also form their own opinion of HCW Biologics' value that differs from its market value or its book value, called intrinsic value, which is HCW Biologics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because HCW Biologics' market value can be influenced by many factors that don't directly affect HCW Biologics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between HCW Biologics' value and its price as these two are different measures arrived at by different means. Investors typically determine if HCW Biologics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, HCW Biologics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.